Arrythmia Clinical Trial
Official title:
"Arrhythmia and Conduction Disorders: TowArd Pathophysiology Based Treatment" ADAPT Biobank
The 'ADAPT' Biobank is a collection of body material and data from patients with or at risk of cardiac arrhythmias who underwent or will undergo (non-) invasive treatment for this disease. Its main objective is to obtain a comprehensive collection of patient information and material to facilitate research and gain better insight into the complex pathophysiology of the different arrhythmias, the multifactorial process, the heterogeneity in clinical presentation, and prognosis. Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.
The pathophysiological process of many cardiac arrhythmias is complex because of its multifactorial character. Despite extensive research that has already been performed in the field of electrophysiology the exact pathophysiological process of the different arrhythmias remains incompletely understood. The ability to identify subgroups of patients within a population with the same type of arrhythmia that can benefit from a specific treatment strategy might provide more individualized therapeutic opportunities, improve prognostication or provide preventive opportunities in patient with cardiac arrhythmias. Biobanks can make a valuable contribution to the development of diagnostic, preventive and therapeutic methods. More insights into the correlations between genes, environmental factors and susceptibility to illness may be of great value. The 'ADAPT' Biobank has been designed to establish a systematic and qualitative collection of bodily materials for future research in the cardiovascular field. The Biobank includes bodily material of patients with cardiac arrhythmias undergoing (non-) invasive treatment or control patients undergoing cardiothoracic surgery. Clinical data related to the cardiac arrhythmic disease is recorded. The data and samples will be linked to the participants' medical records to allow longitudinal follow-up. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00376532 -
Extracellular Matrix Marker of Arrhythmia Risk (EMMA)
|
N/A | |
Recruiting |
NCT04848844 -
The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)
|
||
Completed |
NCT06039397 -
The Effect of Semi Fowler 30' Right Lateral on Cardiac Output in Acute Heart Failure
|
N/A | |
Completed |
NCT04025762 -
24/7 Closed-loop in Older Subjects With Type 1 Diabetes
|
N/A | |
Not yet recruiting |
NCT03619018 -
All Inclusive KODEX - EPD™ Study Patient Specific Optimized Therapy (PSOT) Study
|
||
Completed |
NCT03786640 -
Abbott Brady 3T MRI PMCF
|
||
Recruiting |
NCT05932602 -
AVEIR DR Coverage With Evidence Development (CED) Study
|
||
Recruiting |
NCT05935007 -
Aveir DR Real-World Evidence Post-Approval Study
|
||
Recruiting |
NCT01988064 -
Face to Face vs. Group Training Methods on Pulse Rate Taking in Patients With Cardiovascular Diseases.
|
N/A | |
Recruiting |
NCT06310707 -
Arrhythmia Identification in Syncope Patients: ePatch® Versus 24h Holter
|
N/A | |
Terminated |
NCT03481413 -
Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study
|
||
Recruiting |
NCT05443321 -
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
|
N/A | |
Recruiting |
NCT03801681 -
ARrhythmias in MYocarditis
|
||
Completed |
NCT03628534 -
SERF VT Ablation Early Feasibility Study (EFS)
|
N/A | |
Recruiting |
NCT05034432 -
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
|
Phase 4 | |
Recruiting |
NCT04856267 -
Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders
|
||
Not yet recruiting |
NCT06414447 -
Electrocardiogram (ECG) Validation Study
|
||
Completed |
NCT02401659 -
Importance of Patient´s Satisfaction With Telemedicine Based on Monitoring Systems
|
N/A | |
Recruiting |
NCT05790642 -
Comparison of Different Non-invasive Methods to Assess Pulse Wave Analysis
|
||
Recruiting |
NCT04833712 -
Stereotactic Radioablation for the Treatment of Refractory Atrial Fibrillation
|
N/A |